Clinical Trial Update: A Clinical Trial to Evaluate the Efficacy and Safety of CKD-825 in Patients With Atrial Fibrillation [Phase 3]

View source ↗

Summary

Clinical trial update for CKD-825 in atrial fibrillation, Phase 3, with unspecified status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• CKD-825

Snippet

Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Atrial Fibrillation | Phase 3 | Status: UNKNOWN